Lung Kee (Bermuda) Holdings Limited
Lung Kee (Bermuda) Holdings Limited (0255.HK) Stock Overview
Explore Lung Kee (Bermuda) Holdings Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
852.8M
P/E Ratio
-62.37
EPS (TTM)
$-0.02
ROE
-0.01%
0255.HK Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Lung Kee (Bermuda) Holdings Limited (0255.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 46.55, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.79.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -62.37 and a market capitalization of 852.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
Lung Kee (Bermuda) Holdings Limited, an investment holding company, manufactures and markets mold bases and related products in the People's Republic of China and internationally. The company was founded in 1975 and is headquartered in Sha Tin, Hong Kong. Lung Kee (Bermuda) Holdings Limited is a subsidiary of Pan Island Investments Limited.
Tit Lung Siu
3,000
Unit A, Kings Wing Plaza 2, Sha Tin
1993